Treatment of Salmonella Infection
For non-typhoidal Salmonella gastroenteritis in immunocompetent adults and children >3 months, antimicrobial therapy is NOT recommended unless there are risk factors for invasive disease. 1, 2
When to Treat vs. Observe
DO NOT TREAT (watchful waiting):
- Immunocompetent patients with uncomplicated gastroenteritis
- Mild-moderate diarrhea without systemic symptoms
- Children >3 months without risk factors
- Rationale: Antibiotics do not shorten symptom duration, may prolong fecal shedding, and promote resistance 1, 3, 4
TREAT with antimicrobials:
- Infants <3 months of age (high risk for bacteremia and extraintestinal spread) 1, 2, 4
- Immunocompromised patients (HIV, cancer, transplant recipients) 5, 6, 7
- Invasive disease: bacteremia, sepsis, meningitis, osteomyelitis 6, 1
- High-risk conditions: sickle cell disease, cardiac valvular disease, atherosclerosis (age >50), significant joint disease 7, 3
- Severe illness: fever ≥38.5°C with signs of sepsis, dysentery 1, 2
Antimicrobial Regimens by Clinical Scenario
Non-Typhoidal Salmonella Gastroenteritis (when treatment indicated):
First-line choices (based on susceptibility):
- Ciprofloxacin 500 mg PO twice daily for 7-14 days (adults) 6, 7, 1
- Azithromycin 500 mg PO daily (preferred in children and areas with fluoroquinolone resistance) 1, 8, 3
- Ceftriaxone 2 g IV daily (third-generation cephalosporin for children or severe cases) 6, 1, 8
Alternative agents (if susceptible):
- Amoxicillin 500 mg PO three times daily 6
- TMP-SMX 160/800 mg PO twice daily 6
- Levofloxacin 500 mg PO daily 6
Duration of Therapy:
- CD4+ >200 cells/µL or immunocompetent with mild disease: 7-14 days 7
- Advanced HIV (CD4+ <200) or severe immunosuppression: 2-6 weeks 7
- Bacteremia: Start with combination therapy (ceftriaxone 2g IV daily + ciprofloxacin 500 mg IV twice daily), then de-escalate based on susceptibilities 6
Typhoidal Salmonella (S. Typhi or S. Paratyphi):
First-line:
- Ceftriaxone or Ciprofloxacin 1
- Azithromycin (increasingly preferred due to fluoroquinolone resistance, especially from South Asia) 1, 4
Alternatives (if susceptible):
- Ampicillin or TMP-SMX 1
Special Populations:
HIV-infected patients with bacteremia:
- Require long-term suppressive therapy (secondary prophylaxis) to prevent recurrence 5, 9, 7
- Ciprofloxacin 500 mg PO twice daily for >2 months 9, 10
- Alternative: another active agent based on susceptibilities 9
Pregnant women:
- Avoid fluoroquinolones 5
- Use: Ampicillin, ceftriaxone, cefotaxime, or TMP-SMX 5
- Treat all Salmonella gastroenteritis in pregnancy (risk of placental/amniotic fluid infection) 5
Children:
- <3 months: Ceftriaxone, cefotaxime, ampicillin, or TMP-SMZ 5
- >3 months with risk factors: Azithromycin preferred (avoid fluoroquinolones in children unless no alternative) 5, 11, 1
- Fluoroquinolones: Use with caution, only if no alternatives exist 5, 11
Neutropenic/cancer patients:
- Ciprofloxacin 400 mg IV twice daily or 500 mg PO twice daily 6
- Alternatives: Levofloxacin 500 mg daily, amoxicillin, or TMP-SMX (depending on susceptibility) 6
Critical Considerations
Resistance Patterns:
- Fluoroquinolone resistance is increasing globally, particularly from South/Southeast Asia 11, 1, 8
- Azithromycin shows less resistance development and is increasingly preferred 8, 3
- Multidrug resistance (to ampicillin, TMP-SMX, chloramphenicol) is common 4, 12
- Always obtain susceptibility testing for invasive disease 6, 1
Common Pitfalls:
- Do NOT use fluoroquinolones for Shigella if ciprofloxacin MIC ≥0.12 μg/mL (even if reported "susceptible") 1
- Avoid empiric antibiotics for bloody diarrhea in immunocompetent patients unless specific criteria met (prevents HUS complications with STEC) 1, 2
- Antiperistaltic agents contraindicated in children and with invasive diarrhea 5
- Treating uncomplicated gastroenteritis may prolong carrier state 7, 3